Home / Products / Biosynthesis Chemicals / Enzyme Inhibitors / Monocarboxylate Transporter (MCT) Inhibitors /

Monocarboxylate Transporter (MCT) Inhibitors

Monocarboxylate transporter (MCT) inhibitors are a class of compounds designed to target and inhibit the activity of MCT proteins MCTs are membrane transporters responsible for the movement of monocarboxylate molecules such as lactate pyruvate and ketone bodies across cell membranes By inhibiting the function of MCTs these inhibitors have the potential to modulate various physiological processes and have implications in the treatment of diseases such as cancer metabolic disorders and neurological disorders Our company offers a range of MCT inhibitors that are carefully designed and optimized to provide effective and selective inhibition enabling researchers to explore the therapeutic potential of these important transporters

Get A Quote
Products Application Supporting Data Resources Related Products


Catalog Number Chemical Name CAS # Price
EI-0288 AZD-3965 1448671-31-5 Online Inquiry
EI-0347 BAY-8002 724440-27-1 Online Inquiry
EI-1755 Phloretin 60-82-2 Online Inquiry
EI-2358 α-Cyano-4-hydroxycinnamic acid 28166-41-8 Online Inquiry


The Monocarboxylate Transporter (MCT) inhibitors have a wide range of applications in both research and medicine In research MCT inhibitors are used to study the role of monocarboxylate transporters in various physiological processes By selectively blocking these transporters scientists can examine the impact on cellular metabolism energy production and lactate transport

In the field of medicine MCT inhibitors have shown promise in the treatment of various diseases particularly cancer Cancer cells have an altered metabolism and rely heavily on glycolysis for energy production By inhibiting MCTs these inhibitors can disrupt the transportation of lactate impairing cancer cell growth and potentially enhancing the effectiveness of other anticancer treatments

MCT inhibitors also have potential applications in metabolic disorders such as diabetes and obesity By inhibiting the transport of monocarboxylates these inhibitors can modulate glucose and lipid metabolism offering potential therapeutic options for managing these conditions

Overall the diverse applications of MCT inhibitors highlight their significance in unraveling the complexities of cellular metabolism and their potential as therapeutic targets for a range of diseases

Supporting Data


Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.


There is no product in your cart.